Literature DB >> 30169601

Basal ganglia and cerebellar pathology in X-linked dystonia-parkinsonism.

Henrike Hanssen1,2, Marcus Heldmann2, Jannik Prasuhn1,2, Volker Tronnier3, Dirk Rasche3, Cid C Diesta4, Aloysius Domingo1, Raymond L Rosales5, Roland D Jamora6, Christine Klein1, Thomas F Münte2, Norbert Brüggemann1,2.   

Abstract

X-linked dystonia-parkinsonism is a neurodegenerative movement disorder characterized by adult-onset dystonia combined with parkinsonism over the disease course. Previous imaging and pathological findings indicate exclusive striatal atrophy with predominant pathology of the striosomal compartment in the dystonic phase of X-linked dystonia-parkinsonism. The striosome occupies 10-15% of the entire striatal volume and the density of striosomes follows a rostrocaudal gradient with the rostral striatum being considered striosome-rich. Recent quantitative MRI analyses provided evidence for an additional involvement of the white matter and the pallidum. In this study, we aimed to (i) disentangle the degree of atrophy in the different subdivisions of the striatum; (ii) investigate changes of cortical morphology; and (iii) elucidate the role of the cerebellum in X-linked dystonia-parkinsonism. T1-weighted MRI scans were acquired in 17 male X-linked dystonia-parkinsonism patients with predominant dystonia (40.1 ± 7.5 years) and 17 ethnicity-matched male healthy controls (35.2 ± 7.4 years). Voxel-based morphometry used a region of interest-based approach for the basal ganglia and primary motor cortex, whole brain analysis, and a separate analysis of the cerebellum. Cortical thickness and subcortical volume were measured. Volume loss in X-linked dystonia-parkinsonism affected all parts of the striatum (-29% voxel intensity) but was most pronounced in the associative subdivision (-41%; P < 0.001). The volume loss also involved the external and internal pallidum, albeit to a lesser extent than the striatum (-19% and -12%, P<0.001). Cortical thickness was reduced in the frontal (-4.3%) and temporal cortex (-6.1%). In addition, we found grey matter pathology in the associative part of the cerebellum and increased voxel intensities in the anterior sensorimotor part of the cerebellum and the dorsal ponto-mesencephalic brainstem. Taken together, our analysis of subcortical and cortical grey matter in the dystonic phase of X-linked dystonia-parkinsonism showed that (i) the striosome-enriched rostral striatum was most severely affected; and (ii) cortical thickness was only reduced in those regions that predominantly have anatomical connections to striosomes. Moreover, the cerebellum may be implicated in both disease-related and compensatory changes, highlighting the significance of the cerebellum in the pathophysiology of dystonia.

Entities:  

Mesh:

Year:  2018        PMID: 30169601     DOI: 10.1093/brain/awy222

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  16 in total

1.  Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism.

Authors:  Norbert Brüggemann; Aloysius Domingo; Dirk Rasche; Christian K E Moll; Raymond L Rosales; Roland Dominic G Jamora; Henrike Hanssen; Alexander Münchau; Julia Graf; Anne Weissbach; Vera Tadic; Cid C Diesta; Jens Volkmann; Andrea Kühn; Thomas F Münte; Volker Tronnier; Christine Klein
Journal:  JAMA Neurol       Date:  2019-02-01       Impact factor: 18.302

Review 2.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-24       Impact factor: 3.575

Review 3.  Arching deep brain stimulation in dystonia types.

Authors:  Han-Joon Kim; Beomseok Jeon
Journal:  J Neural Transm (Vienna)       Date:  2021-03-19       Impact factor: 3.575

Review 4.  X-Linked Dystonia-Parkinsonism: recent advances.

Authors:  D Cristopher Bragg; Nutan Sharma; Laurie J Ozelius
Journal:  Curr Opin Neurol       Date:  2019-08       Impact factor: 5.710

Review 5.  Contemporary functional neuroanatomy and pathophysiology of dystonia.

Authors:  Norbert Brüggemann
Journal:  J Neural Transm (Vienna)       Date:  2021-01-24       Impact factor: 3.575

6.  Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-Parkinsonism.

Authors:  Cara Fernandez-Cerado; G Paul Legarda; M Salvie Velasco-Andrada; Abegail Aguil; Niecy G Ganza-Bautista; J Benedict B Lagarde; Jasmin Soria; Roland Dominic G Jamora; Patrick J Acuña; Charles Vanderburg; Ellen Sapp; Marian DiFiglia; Micaela G Murcar; Lindsey Campion; Laurie J Ozelius; Amy K Alessi; Malvindar K Singh-Bains; Henry J Waldvogel; Richard L M Faull; Regina Macalintal-Canlas; Edwin L Muñoz; Ellen B Penney; Mark A Ang; Cid Czarina E Diesta; D Cristopher Bragg; Geraldine Acuña-Sunshine
Journal:  J Neural Transm (Vienna)       Date:  2021-01-13       Impact factor: 3.575

7.  Cerebellar Direct Current Stimulation (ctDCS) in the Treatment of Huntington's Disease: A Pilot Study and a Short Review of the Literature.

Authors:  Tommaso Bocci; Davide Baloscio; Roberta Ferrucci; Ferdinando Sartucci; Alberto Priori
Journal:  Front Neurol       Date:  2020-12-03       Impact factor: 4.003

Review 8.  Combined dystonias: clinical and genetic updates.

Authors:  Anne Weissbach; Gerard Saranza; Aloysius Domingo
Journal:  J Neural Transm (Vienna)       Date:  2020-10-24       Impact factor: 3.575

9.  Brain Regional Differences in Hexanucleotide Repeat Length in X-Linked Dystonia-Parkinsonism Using Nanopore Sequencing.

Authors:  Charles Jourdan Reyes; Björn-Hergen Laabs; Susen Schaake; Theresa Lüth; Raphaela Ardicoglu; Aleksandar Rakovic; Karen Grütz; Daniel Alvarez-Fischer; Roland Dominic Jamora; Raymond L Rosales; Imke Weyers; Inke R König; Norbert Brüggemann; Christine Klein; Valerija Dobricic; Ana Westenberger; Joanne Trinh
Journal:  Neurol Genet       Date:  2021-07-06

10.  TAF1 Transcripts and Neurofilament Light Chain as Biomarkers for X-linked Dystonia-Parkinsonism.

Authors:  Jamal Al Ali; Christine A Vaine; Shivangi Shah; Lindsey Campion; Ahmad Hakoum; Melanie L Supnet; Patrick Acuña; Gabrielle Aldykiewicz; Trisha Multhaupt-Buell; Niecy G M Ganza; John B B Lagarde; Jan K De Guzman; Criscely Go; Benjamin Currall; Bianca Trombetta; Pia K Webb; Michael Talkowski; Steven E Arnold; Pike S Cheah; Naoto Ito; Nutan Sharma; D Cristopher Bragg; Laurie Ozelius; Xandra O Breakefield
Journal:  Mov Disord       Date:  2020-09-25       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.